Cell Genesys

Mar 11, 08
	NEW STORY
08:30 ET	Cell Genesys to Present at the Cowen and Company and the Lehman Brothers Healthcare Investor Conferences
Feb 28, 08
16:00 ET	Cell Genesys Reports Fourth Quarter and Year-End 2007 Results
Feb 21, 08
08:30 ET	Cell Genesys to Webcast Fourth Quarter and Year-End 2007 Conference Call
Feb 15, 08
08:30 ET	Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
Feb 04, 08
08:30 ET	Cell Genesys to Present at the BIO CEO and Investor Conference
Jan 14, 08
09:00 ET	Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
Jan 02, 08
08:30 ET	Cell Genesys to Present at the 26th Annual JPMorgan Healthcare Conference
Dec 20, 07
14:21 ET	Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million
Nov 06, 07
08:30 ET	Cell Genesys to Present at the JMP Securities Sector Focus Conference
Nov 01, 07
16:00 ET	Cell Genesys Reports Third Quarter 2007 Financial Results
Oct 30, 07
08:30 ET	Cell Genesys to Present at the Rodman and Renshaw 9th Annual Healthcare Conference
Oct 25, 07
08:30 ET	Cell Genesys to Webcast Third Quarter 2007 Conference Call
Oct 03, 07
08:30 ET	Cell Genesys to Present at the BIO Investor Forum
Sep 18, 07
08:30 ET	Cell Genesys to Present at the UBS Global Life Sciences Conference
Sep 04, 07
08:30 ET	Cell Genesys to Present at the Bear Stearns 20th Annual Healthcare Conference
Aug 07, 07
16:00 ET	Cell Genesys Reports Second Quarter 2007 Results
Aug 01, 07
08:30 ET	Cell Genesys to Webcast Presentation at the Canaccord Adams 27th Annual Global Growth Conference
Jul 31, 07
16:00 ET	Cell Genesys to Webcast Second Quarter 2007 Conference Call
Jul 10, 07
08:30 ET	Cell Genesys Completes Patient Recruitment for First Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
Jun 06, 07
07:00 ET	Cell Genesys to Webcast Presentation at The Needham Biotechnology and Medical Technology Conference
Jun 04, 07
07:30 ET	Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
07:00 ET	Cell Genesys and Medarex Report Follow-Up Data From a Phase 1 Combination Therapy Trial With GVAX Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
May 10, 07
16:05 ET	Cell Genesys Reports First Quarter 2007 Results
May 09, 07
07:00 ET	Cell Genesys Provides Update on Clinical Program for GVAX Immunotherapy for Leukemia
May 07, 07
07:00 ET	Cell Genesys to Webcast Presentation at the Acumen Biofin Rodman & Renshaw Global Healthcare Conference
May 03, 07
07:00 ET	Cell Genesys to Webcast First Quarter 2007 Conference Call
May 02, 07
16:00 ET	Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease
May 01, 07
06:26 ET	Cell Genesys Files New Shelf Registration Statement
Apr 17, 07
07:00 ET	Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces a Broad, Patient-Specific Antibody Response
Apr 16, 07
10:00 ET	Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of CERE-120 Demonstrating Improved Motor Function in Parkinson's Patients
Apr 13, 07
07:00 ET	Ceregene Enrolling Patients for Phase 2 Clinical Trial of Parkinson's Disease
Apr 11, 07
08:30 ET	Cell Genesys Announces Registered Direct Common Stock And Warrant Offering of $60 Million
Apr 03, 07
07:00 ET	Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
Mar 12, 07
07:00 ET	Cell Genesys to Webcast Presentation at the Lehman Brothers Global Healthcare Conference
Mar 06, 07
16:05 ET	Cell Genesys to Webcast Presentation at the SG Cowen & Co. Health Care Conference
Mar 01, 07
16:15 ET	Cell Genesys Reports Fourth Quarter and Full Year 2006 Results
Feb 22, 07
07:00 ET	Cell Genesys To Webcast Fourth Quarter / Year-End 2006 Conference Call
07:00 ET	Cell Genesys and Medarex Announce Encouraging Follow-Up Results from a Phase 1 Combination Therapy Trial With GVAX(TM) Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
Feb 07, 07
07:00 ET	Cell Genesys to Webcast Presentation at the BIO CEO & Investor Conference
Feb 05, 07
07:00 ET	Cell Genesys Secures $75 Million Committed Equity Financing Facility
Jan 22, 07
07:00 ET	Cell Genesys Announces Encouraging Follow-Up Survival Data From Phase 2 Clinical Trial of GVAX(R) Immunotherapy for Pancreatic Cancer
Jan 03, 07
07:00 ET	Cell Genesys to Webcast Presentation at the JPMorgan Healthcare Conference
Nov 10, 06
07:00 ET	Cell Genesys to Webcast Presentation at the Credit Suisse Healthcare Conference
Nov 02, 06
16:30 ET	Cell Genesys Reports Third Quarter 2006 Financial Results
Oct 31, 06
16:30 ET	Cell Genesys Announces Management Change
07:00 ET	Cell Genesys to Present at Rodman & Renshaw and Cowen and Company Healthcare Conferences
Oct 26, 06
07:00 ET	Cell Genesys to Webcast Third Quarter 2006 Conference Call
Oct 11, 06
07:00 ET	Cell Genesys to Webcast Presentation at the BIO Investor Forum Conference
Oct 10, 06
07:00 ET	Ceregene Announces Promising Phase 1 Results From Gene Therapy Trial for Parkinson's Disease
Sep 19, 06
07:00 ET	Cell Genesys to Webcast Presentation at the UBS Global Life Sciences Conference
Sep 01, 06
07:00 ET	Cell Genesys to Webcast Presentation at the Bear Stearns Healthcare Conference
Aug 31, 06
07:00 ET	Cell Genesys to Webcast Presentation at the Newsmakers in the Biotech Industry Conference
Aug 03, 06
16:15 ET	Cell Genesys Reports Second Quarter 2006 Financial Results
Aug 01, 06
07:00 ET	Cell Genesys to Webcast Presentation at the Canaccord Adams Summer Seminar
Jul 27, 06
07:00 ET	Cell Genesys to Webcast Second Quarter 2006 Conference Call
Jul 18, 06
07:00 ET	Cell Genesys Launches Expanded Multiple-Dose Phase 1 Trial of CG0070 in Recurrent Bladder Cancer
Jul 05, 06
07:00 ET	Cell Genesys Announces Publication of Encouraging Phase 1/2 Clinical Results For GVAX(R) Immunotherapy for Prostate Cancer in Early Stage Patients Before Receiving Hormone Therapy
Jun 08, 06
16:30 ET	Cell Genesys to Webcast Presentation at the Needham Biotechnology and Medical Technology Conference
Jun 05, 06
07:00 ET	Cell Genesys Recaps Two Weekend Data Presentations From 2006 ASCO Annual Meeting
Jun 03, 06
08:00 ET	Cell Genesys and Medarex Announce Encouraging Interim Results from a Phase 1 Combination Therapy Trial With GVAX(R) Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
May 22, 06
07:00 ET	Cell Genesys Reports Interim Results of CG0070 Phase 1 Trial in Bladder Cancer
May 10, 06
07:00 ET	Cell Genesys Receives Fast Track Status for GVAX(R) Immunotherapy for Prostate Cancer
May 09, 06
08:00 ET	Cell Genesys to Webcast Presentation at the Rodman & Renshaw Global Healthcare Conference
May 08, 06
19:44 ET	Cell Genesys Reports First Quarter 2006 Financial Results
May 02, 06
08:00 ET	Cell Genesys to Webcast First Quarter 2006 Conference Call
Mar 30, 06
07:01 ET	Cell Genesys to Present Data From GVAX(R) Cancer Immunotherapy and Oncolytic Virus Therapy Programs at 2006 AACR Annual Meeting
Mar 21, 06
17:17 ET	Cell Genesys to Webcast Presentation at the Bear Biotech West Coast Confab
Mar 15, 06
08:02 ET	Cell Genesys Secures $75 Million Committed Equity Financing Facility
Mar 13, 06
07:01 ET	Cell Genesys to Present Data From Two GVAX(R) Cancer Immunotherapy Clinical Trials at 2006 ASCO Annual Meeting
Mar 02, 06
08:02 ET	Cell Genesys to Webcast Presentation at the Lehman Brothers Global Healthcare Conference
Feb 28, 06
08:02 ET	Cell Genesys to Webcast Presentation at the SG Cowen & Co. Health Care Conference
Feb 27, 06
07:01 ET	Cell Genesys Reports Encouraging Follow-Up Survival Data From Second Phase 2 Trial of GVAX(R) Immunotherapy for Prostate Cancer
Feb 21, 06
21:41 ET	Cell Genesys Reports Fourth Quarter and Full Year 2005 Results
Feb 13, 06
08:01 ET	Cell Genesys to Webcast Fourth Quarter / Year-End 2005 Conference Call
Feb 08, 06
16:05 ET	Cell Genesys to Webcast Presentations at the BIO CEO & Investor Conference
Jan 03, 06
07:02 ET	Cell Genesys to Webcast Presentation at the JPMorgan Healthcare Conference
Dec 12, 05
08:30 ET	Cell Genesys Reports Positive Results From Phase 2 Trial of GVAX(R) Vaccine for Leukemia in Chronic Myelogenous Leukemia
Nov 15, 05
09:02 ET	Cell Genesys Announces Favorable 2-Year Survival Data From Phase 2 Clinical Trial of GVAX(R) Vaccine for Pancreatic Cancer
Nov 03, 05
16:05 ET	Cell Genesys to Webcast Presentation at the SG Cowen Global Life Sciences Conference
Nov 02, 05
16:07 ET	Cell Genesys Reports Third Quarter 2005 Financial Results
Nov 01, 05
16:05 ET	Cell Genesys to Webcast Presentation at the Rodman & Renshaw Techvest Healthcare Conference
Oct 31, 05
07:02 ET	Cell Genesys Confirms November 3 Webcast of Its Third Quarter 2005 Financial Results Conference Call
Oct 20, 05
07:05 ET	Cell Genesys Confirms Upcoming Clinical Data Presentations for Two GVAX(R) Cancer Vaccine Programs
Oct 12, 05
16:05 ET	Cell Genesys to Webcast Presentation at the BIO Investor Forum Conference
Sep 21, 05
07:00 ET	Ceregene Reports Initiation of Phase 1 Clinical Trial of Novel Gene Therapy for Patients With Parkinson's Disease
Sep 19, 05
07:02 ET	Cell Genesys to Webcast Presentation at the UBS Global Life Sciences Conference
Jul 27, 05
07:05 ET	Cell Genesys to Webcast Presentation at the Adams Harkness Summer Seminar Conference
Jul 25, 05
16:05 ET	Cell Genesys Reports Second Quarter 2005 Financial Results
Jul 19, 05
07:04 ET	Cell Genesys to Webcast Second Quarter 2005 Conference Call
Jul 12, 05
07:00 ET	Ceregene Adds Biotech Executive John Walker to Its Board of Directors
Jul 05, 05
07:00 ET	Cell Genesys Initiates Second Phase 3 Clinical Trial of GVAX(R) Vaccine for Prostate Cancer
Jul 04, 05
02:30 ET	Cell Genesys Reports Clinical Data From GVAX(R) Vaccine for Lung Cancer Program
Jun 07, 05
07:00 ET	Cell Genesys Announces Strategic Restructuring of Business to Focus on Most Advanced Programs
Jun 01, 05
07:01 ET	Cell Genesys Appoints Sharon E. Tetlow Senior Vice President and Chief Financial Officer
May 19, 05
07:00 ET	Cell Genesys to Webcast Presentation at the Needham Biotechnology Conference
May 18, 05
07:00 ET	Cell Genesys Receives Special Protocol Assessment From FDA for Second Phase 3 Trial of GVAX(R) Vaccine for Prostate Cancer
May 17, 05
08:00 ET	Cell Genesys Reports Encouraging Follow-Up Data From Second Phase 2 Trial of GVAX(R) Vaccine for Prostate Cancer
May 16, 05
13:30 ET	Cell Genesys Reports Additional Positive Data From Phase 2 Trial of GVAX(R) Vaccine for Leukemia
May 14, 05
09:00 ET	Cell Genesys to Webcast Presentation at the Banc of America Securities Health Care Conference
Apr 29, 05
18:46 ET	Cell Genesys to Webcast Presentation at the Rodman & Renshaw Techvest Global Healthcare Conference
Apr 27, 05
16:50 ET	Cell Genesys Reports First Quarter 2005 Financial Results
Apr 26, 05
07:04 ET	Cell Genesys Launches Phase 1 Trial of CG0070 in Recurrent Bladder Cancer
Apr 25, 05
07:00 ET	Ceregene Scientific Co-Founder Publishes Alzheimer's Disease Clinical Trial Results in Nature Medicine
Apr 21, 05
07:02 ET	Cell Genesys to Webcast First Quarter 2005 Conference Call
Apr 19, 05
07:02 ET	Cell Genesys Reports Potential Breakthrough in Antibody Production Technology
Apr 18, 05
07:01 ET	Cell Genesys Reports Synergistic Antitumor Activity for GVAX(R) Cancer Vaccine and Anti-Angiogenesis Therapy in Preclinical Studies
Mar 23, 05
07:00 ET	Cell Genesys to Webcast Presentation at the Lehman Brothers Global Healthcare Conference
Mar 11, 05
07:01 ET	Cell Genesys Announces Management Changes
Mar 09, 05
07:00 ET	Cell Genesys to Webcast Presentation at the SG Cowen Annual Health Care Conference
Feb 16, 05
07:01 ET	Cell Genesys to Webcast Presentation at the BIO CEO & Investor Conference
Feb 09, 05
07:01 ET	Ceregene Promotes Raymond Bartus to Senior Vice President and Chief Operating Officer
Jan 24, 05
16:30 ET	Cell Genesys Reports Fourth Quarter and Full Year 2004 Results
Jan 18, 05
07:00 ET	Cell Genesys to Webcast Fourth Quarter/Year-End 2004 Conference Call
Jan 05, 05
07:00 ET	Cell Genesys to Webcast Presentation at the JPMorgan Healthcare Conference
Jan 04, 05
07:00 ET	Cell Genesys Common Stock Delisted From Berlin-Bremen Stock Exchange
Dec 07, 04
07:00 ET	Cell Genesys Reports Encouraging Follow Up Clinical Data From Phase 2 Trial of GVAX(R) Leukemia Vaccine
07:00 ET	Ceregene Expands Clinical Team With the Addition of Matt Kurth and Dan Lee
Nov 17, 04
19:30 ET	Cell Genesys, Inc. Announces Exercise of Initial Purchasers' Option for Additional $35 Million of Convertible Senior Notes
Nov 10, 04
16:31 ET	Cell Genesys to Webcast Presentation at the SG Cowen Global Life Sciences Conference
Oct 25, 04
16:30 ET	Cell Genesys Reports Third Quarter 2004 Financial Results
Oct 20, 04
16:30 ET	Cell Genesys to Webcast Presentation at the Rodman & Renshaw Techvest Healthcare Conference
Oct 19, 04
16:30 ET	Cell Genesys to Webcast Third Quarter 2004 Conference Call
Oct 15, 04
07:03 ET	Cell Genesys, Inc. Announces Pricing of $110 Million of Convertible Senior Notes
Oct 12, 04
16:05 ET	Cell Genesys, Inc. Announces Preliminary Third Quarter 2004 Results
16:05 ET	Cell Genesys, Inc. to Offer $100 Million of Convertible Senior Notes
Sep 21, 04
18:57 ET	Cell Genesys to Webcast Analyst Day Meeting Tuesday, September 28, 2004
07:01 ET	Ceregene Begins Phase I Clinical Trial of Novel Gene Therapy Product for Patients With Alzheimer's Disease
Sep 20, 04
18:53 ET	Cell Genesys to Webcast Presentation at the UBS Global Life Sciences Conference
Aug 19, 04
07:01 ET	Cell Genesys Reports Publication of Additional Results From Phase 1 Clinical Trial of GVAX(R) Pancreatic Cancer Vaccine
Aug 18, 04
04:00 ET	Cell Genesys Launches Phase 1/2 Trial of CG7870 in Combination with Taxotere(R) for Advanced Prostate Cancer
Aug 04, 04
07:02 ET	Ceregene Announces $32 Million Series B Financing
Jul 26, 04
16:05 ET	Cell Genesys Reports Second Quarter Financial Results
Jul 22, 04
07:06 ET	Cell Genesys Demands Delisting of Its Common Stock From Berlin-Bremen Stock Exchange
Jul 20, 04
08:04 ET	Cell Genesys to Webcast Second Quarter 2004 Conference Call
Jul 15, 04
07:05 ET	Cell Genesys Initiates Phase 3 Clinical Trial of GVAX(R) Prostate Cancer Vaccine
Jun 28, 04
06:30 ET	Cell Genesys Announces Initiation of Phase 2 Trial of GVAX(R) Lung Cancer Vaccine in Bronchoalveolar Carcinoma
Jun 26, 04
10:00 ET	Cell Genesys Reports Initial Clinical Data From GVAX(R) Pancreatic Cancer Vaccine Program
Jun 10, 04
09:01 ET	Cell Genesys to Webcast Presentation at the Needham Biotechnology Conference
Jun 07, 04
09:01 ET	Cell Genesys Reports Follow-Up Clinical Data From Phase 2 Trial Of GVAX(R) Prostate Cancer Vaccine
Jun 06, 04
14:00 ET	Cell Genesys Reports Interim Data From Phase 2 Clinical Trial of GVAX(R) Leukemia Vaccine
09:00 ET	Cell Genesys Reports Final Results of Phase 1/2 Trial of CG7870 Oncolytic Virus Therapy for Prostate Cancer
Jun 02, 04
09:05 ET	Cell Genesys to Webcast Presentation at the Pacific Growth Equities Life Sciences Growth Conference
May 10, 04
07:02 ET	Cell Genesys Obtains Special Protocol Assessment From FDA For Phase 3 Trial of GVAX(R) Prostate Cancer Vaccine
May 06, 04
09:01 ET	Cell Genesys to Webcast Presentation at the Rodman & Renshaw Techvest Global Healthcare Conference
Apr 29, 04
07:07 ET	Ceregene Confirms Plans to Further Develop Alzheimer's Disease Gene Therapy
Apr 26, 04
16:05 ET	Cell Genesys Reports First Quarter Financial Results
Apr 20, 04
08:06 ET	Cell Genesys to Webcast First Quarter 2004 Conference Call
Mar 30, 04
07:01 ET	Cell Genesys Reports Preclinical Data for Oncolytic Virus Therapy Product With Ability to Target Multiple Cancers
Mar 29, 04
07:02 ET	Cell Genesys Reports Synergistic Antitumor Activity for GVAX(R) Cancer Vaccine Plus Docetaxel Chemotherapy in Preclinical Studies
Mar 25, 04
07:01 ET	Cell Genesys to Present Preclinical Data From GVAX(R) Cancer Vaccine and Other Programs at 2004 AACR Annual Meeting
Mar 24, 04
07:00 ET	Cell Genesys to Update Results from GVAX(R) Prostate Cancer Vaccine and Other Clinical Trial Programs at 2004 ASCO Annual Meeting
Mar 23, 04
07:03 ET	Cell Genesys Announces Completion of Common Stock Offering and Exercise of Underwriters' Over-Allotment Option
Mar 19, 04
07:30 ET	Cell Genesys to Webcast Presentation at the Wells Fargo Securities Healthcare Conference
Mar 17, 04
07:02 ET	Cell Genesys Announces Pricing of Common Stock Offering
Mar 04, 04
17:29 ET	Cell Genesys Announces Proposed Offering of Common Stock
Feb 23, 04
07:30 ET	Cell Genesys to Webcast Presentation at the BIO CEO & Investor Conference
Feb 20, 04
13:45 ET	Cell Genesys Confirms Publication of Scientific Paper on GVAX(R) Lung Cancer Vaccine
Jan 26, 04
16:12 ET	Cell Genesys Reports Fourth Quarter and 2003 Results
Jan 21, 04
08:30 ET	Cell Genesys to Webcast Fourth Quarter / Year-End 2003 Conference Call
Jan 12, 04
07:01 ET	Cell Genesys Elects Dennis Winger To Board of Directors
Jan 06, 04
18:08 ET	Cell Genesys to Webcast Presentation at the JPMorgan Healthcare Conference
Dec 06, 03
22:09 ET	Cell Genesys Reports Interim Clinical Data From Phase 2 Trial of GVAX(R) Leukemia Vaccine
Dec 04, 03
09:00 ET	Cell Genesys to Webcast Presentation At The Harris Nesbitt Gerard Healthcare Investor Conference
Oct 27, 03
16:02 ET	Cell Genesys Reports Third Quarter Financial Results
Oct 22, 03
09:02 ET	Cell Genesys to Webcast Third Quarter 2003 Conference Call
Oct 16, 03
09:00 ET	Cell Genesys to Webcast Presentation At The Rodman & Renshaw Techvest Healthcare Conference
Sep 16, 03
08:31 ET	Cell Genesys to Webcast Presentation at the UBS Global Life Sciences Conference
Sep 02, 03
07:01 ET	Cell Genesys Reports Positive Long-Term Follow-Up Data From Phase 1 Trial Of GVAX(R) Melanoma Vaccine
Aug 28, 03
07:00 ET	Cell Genesys to Receive $16.8 Million in Connection With Previously Terminated GVAX(R) Collaboration Agreement
Jul 28, 03
15:59 ET	Cell Genesys Reports Second Quarter Financial Results
Jul 24, 03
10:00 ET	Cell Genesys to Webcast Second Quarter 2003 Conference Call
Jul 23, 03
07:05 ET	Cell Genesys and Novartis Enter Into Global Strategic Alliance for Oncolytic Virus Therapy Products
Jun 19, 03
10:00 ET	Cell Genesys to Webcast Company Presentation from the Bio 2003 Annual Convention
Jun 02, 03
09:02 ET	Cell Genesys Reports Initial Clinical Data From Phase 1/2 Trial of GVAX(R) Myeloma Vaccine
09:02 ET	Cell Genesys Reports Interim Clinical Data From Phase 2 Trial of GVAX(R) Prostate Cancer Vaccine
May 29, 03
10:00 ET	Cell Genesys to Webcast Presentation at The Needham & Company Second Annual Biotechnology Conference
Apr 28, 03
16:02 ET	Cell Genesys Reports First Quarter Financial Results
Apr 23, 03
11:00 ET	Cell Genesys to Webcast First Quarter 2003 Conference Call
Apr 22, 03
07:03 ET	Cell Genesys Launches Phase 1/2 Trial of CG7870 Plus Radiation Therapy in Early-Stage Prostate Cancer
Apr 02, 03
07:01 ET	Cell Genesys to Present Data From GVAX(R) Prostate Cancer and Myeloma Vaccine Clinical Trials at 2003 ASCO Annual Meeting
Apr 01, 03
07:02 ET	Cell Genesys Launches Expanded Phase 2 Trial of GVAX(R) Lung Cancer Vaccine
Feb 20, 03
10:00 ET	Cell Genesys to Webcast Presentation at the BIO CEO and Investor Conference
Feb 13, 03
18:05 ET	Cell Genesys Reports Encouraging Update From Initial Clinical Trial of GVAX(R) Lung Cancer Vaccine
Feb 04, 03
07:00 ET	Cell Genesys Increases Cancer Product Focus and Eliminates Broad-Based Gene Therapy Research
Jan 29, 03
16:03 ET	Cell Genesys Reports Fourth Quarter and 2002 Results
Jan 24, 03
14:55 ET	Cell Genesys to Webcast Fourth Quarter / Year-End Conference Call
Jan 22, 03
07:00 ET	Cell Genesys Receives $15 Million from TKT for Remainder of License Fee In Gene Activation License Agreement
Jan 03, 03
09:00 ET	Cell Genesys Invites You to Join Its Company Presentation at the JPMorgan H&Q Healthcare Conference